CorporateEverstone to Exit Burger King India, Ajanta Pharma Set to Invest ₹800 CrBY Outlook Business Desk
CorporateBurger King to Face Legal Trouble in US Over Misleading Ads; Here's What It's Accused OfBY Outlook Business Desk